| TF Name |
Cell-line |
Condition/Source |
Collections |
Species |
Identifiers |
JASPAR ID |
| SRF |
primary vascular smooth muscle cell (C57BL/6 mice) |
Treatment: infected with shNT for 3 days |
Permissive
Robust
|
Mus musculus |
GSE112417
...
|
MA0083.3
|
| SRF |
primary vascular smooth muscle cell (C57BL/6 mice) |
Treatment: infected with shNT for 3 days |
Permissive
Robust
|
Mus musculus |
GSE112417
...
|
MA0083.3
|
| SRF |
primary vascular smooth muscle cell (C57BL/6 mice) |
Treatment: infected with sh2AZ for 3 days |
Permissive
|
Mus musculus |
GSE112417
...
|
MA0083.3
|
| SRF |
primary vascular smooth muscle cell (C57BL/6 mice) |
Treatment: infected with sh2AZ for 3 days |
Permissive
Robust
|
Mus musculus |
GSE112417
...
|
MA0083.3
|
| SRF |
differentiated neural progenitor cells |
Source: Neural progenitor cells expressing no ectopic gene |
Permissive
Robust
|
Mus musculus |
GSE106319
...
|
MA0083.3
|
| SRF |
differentiated neural progenitor cells |
Treatment: transgene of Srf was introduced retrovirally Source: Neural progenitor cells overexpressing Srf |
Permissive
Robust
|
Mus musculus |
GSE106319
...
|
MA0083.3
|
| SRF |
fetal liver |
Source: Hepatoblasts (expressing no ectopic gene) |
Permissive
Robust
|
Mus musculus |
GSE106319
...
|
MA0083.3
|
| SRF |
HEL (Erythro Leukemia) |
Treatment: No treatment, no TPA Source: HEL-iMKL1 cells |
Permissive
Robust
|
Homo sapiens |
GSE112265
...
|
MA0083.3
|
| SRF |
HEL (Erythro Leukemia) |
Treatment: No treatment, no TPA Source: HEL-iMKL1 cells |
Permissive
Robust
|
Homo sapiens |
GSE112265
...
|
MA0083.3
|
| SRF |
HEL (Erythro Leukemia) |
Treatment: Treated with 10ng/ml Dox for 24 hours Source: HEL-iMKL1 cells |
Permissive
Robust
|
Homo sapiens |
GSE112265
...
|
MA0083.3
|
Showing 10 records in page 836
from 963 pages